C
Coastal Research Institute | Fayetteville, NC
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Glecaprevir
BOS-580
Deudomperidone
CIN-102
Etrasimod
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
This is a safety study to evaluate BOS-580 administered subcutaneously with repeated dosing over 12 weeks in Part A or 24 weeks in Part B. Part C is...
Active, not recruiting
Nonalcoholic Steatohepatitis (NASH)
Drug: BOS-580
Drug: Placebo
The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastr...
Enrolling
Diabetic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 2
Hepatitis C Virus (HCV) infection is a global health problem. HCV mainly affects liver cells and causes the liver to become inflamed and damaged. Thi...
Active, not recruiting
Hepatitis C Virus (HCV)
Drug: Glecaprevir/Pibrentasvir (GLE/PIB)
Trial sponsors
C
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems